Table 2 Clinical characteristics of REBUS-TBNA patients
No. | Sex | Age | Lesion diameter (cm) | Lesion location | Extent | No. punctures | Pathology | Diagnosis | Adverse events |
|---|---|---|---|---|---|---|---|---|---|
1 | F | 73 | 6.2 | RML B4 | Mild | 4 | Inflammation | P | NO |
2 | F | 62 | 2.8 | LUL B4 | Mild | 4 | Inflammation | P | NO |
3 | F | 72 | 4.3 | LUL B4b | Mild | 4 | Adenocarcinoma | P | NO |
4 | F | 68 | 2.4 | LUL B4 | Mild | 2 | Blood | N | NO |
5 | M | 82 | 3.7 | RUL B3 | Atretic | 5 | Squamous Carcinoma | P | NO |
6 | F | 69 | 4.1 | RUL B2 | Mild | 5 | Adenocarcinoma | P | NO |
7 | M | 64 | 5 | RUL B3 | Mild | 5 | Inflammation | P | NO |
8 | F | 59 | 4.9 | LUL B4 | Atretic | 3 | ND | N | NO |
9 | M | 64 | 3.8 | LUL B1 + 2 | Mild | 4 | SCLC | P | NO |
10 | M | 77 | 5.3 | RML B5 | Mild | 4 | Adenocarcinoma | P | NO |
11 | M | 70 | 3.8 | RUL B3 | Mild | 5 | Adenocarcinoma | P | NO |
12 | M | 77 | 6.1 | RML B4 | Mild | 3 | Blood | N | NO |
13 | M | 69 | 4.5 | RUL B2 | Atretic | 5 | Granuloma | P | NO |
14 | M | 56 | 4.7 | RUL B3 | Atretic | 5 | Granuloma | P | NO |
15 | M | 78 | 5.2 | RLL B10 | Mild | 3 | ND | N | NO |
16 | F | 60 | 6 | RUL B2 | Mild | 5 | SCLC | P | NO |
17 | M | 55 | 4.8 | LUL B1 + 2 | Mild | 4 | SCLC | P | NO |
18 | M | 29 | 3 | LUL B1 + 2 | Mild | 5 | Granuloma | P | NO |
19 | M | 62 | 4.1 | RUL B2 | Mild | 4 | Adenocarcinoma | P | NO |
20 | M | 55 | 5.2 | RUL B3 | Mild | 5 | Adenocarcinoma | P | NO |
21 | F | 62 | 4.6 | RUL B2 | Atretic | 4 | SCLC | P | NO |
22 | M | 67 | 5.6 | RUL B3 | Mild | 5 | Adenocarcinoma | P | NO |
23 | M | 53 | 4.3 | LLL B10 | Mild | 5 | Adenocarcinoma | P | NO |
24 | M | 65 | 6.7 | RUL B2 | Mild | 5 | Adenocarcinoma | P | NO |
25 | M | 71 | 5.3 | RUL B3 | Mild | 5 | SCLC | P | NO |